Bondarenko Jamieson Insider Trades

Insider Trading History

Track insider trading activity for Bondarenko Jamieson. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BriaCell Therapeutics - Warrants (24/02/2025)
BriaCell Therapeutics - Warrants (24/02/2025) BCTXW
Chairman
Holding Value $153 169,856 shares
Last Trade
Dec 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$52.9k 28,000 shares
$1.89
$0.00
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Chairman
Holding Value $554k 169,856 shares
Last Trade
Dec 28, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.91M 28,000 shares
$68.18
$3.26
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Director
Holding Value $462k 141,856 shares
Last Trade
Dec 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.74M 22,000 shares
$79.05
$3.26
BriaCell Therapeutics - Warrants (24/02/2025)
BriaCell Therapeutics - Warrants (24/02/2025) BCTXW
Director
Holding Value $128 141,856 shares
Last Trade
Dec 20, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$44k 22,000 shares
$2.00
$0.00
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Director
Holding Value $391k 119,856 shares
Last Trade
Aug 01, 2022 Sale
$240M 250,000 shares
$961.50
$3.26
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Director
Holding Value $0 0 shares
Last Trade
Aug 12, 2021 Sale
$6.46M 70,000 shares
$92.25
$3.26
BriaCell Therapeutics
BriaCell Therapeutics BCTX
Director
Holding Value $0 0 shares
Last Trade
Mar 29, 2021 Sale
$7.99M 150,000 shares
$53.25
$3.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up